ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Daveme
|
556 |
227K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
556
|
227K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Daveme
|
556 |
227K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
556
|
227K
|
1
|
|
ASX - By Stock
|
EOS |
Re:
Naval Opportunity for EOS?
|
|
Daveme
|
9 |
3.7K |
1 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
9
|
3.7K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Daveme
|
901 |
280K |
7 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
901
|
280K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
post approval sp guesstimate
|
|
Daveme
|
168 |
54K |
16 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
168
|
54K
|
16
|
|
ASX - By Stock
|
BRK |
Re:
Financial review
|
|
Daveme
|
51 |
15K |
2 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
51
|
15K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Daveme
|
274 |
120K |
2 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
274
|
120K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Full Year Statutory Accounts
|
|
Daveme
|
51 |
21K |
6 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
51
|
21K
|
6
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Full Year Statutory Accounts
|
|
Daveme
|
51 |
21K |
7 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
51
|
21K
|
7
|
|
Commodities
|
GOLD |
Re:
gold
|
|
Daveme
|
126K |
48M |
1 |
18/03/23 |
18/03/23 |
Commodities
|
126K
|
48M
|
1
|
|
ASX - By Stock
|
AGE |
Re:
Ann: Scoping Study - Samphire Uranium Project
|
|
Daveme
|
12 |
5.6K |
1 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
12
|
5.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
Daveme
|
111 |
40K |
1 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
40K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
Daveme
|
618 |
235K |
7 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
618
|
235K
|
7
|
|
ASX - By Stock
|
DCN |
Re:
Ann: Investor Presentation and Briefing
|
|
Daveme
|
11 |
7.2K |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
11
|
7.2K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Biggest short squeeze in history, on it's way
|
|
Daveme
|
353 |
159K |
3 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
353
|
159K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Interest rate hike .. more downside for bnpl industry
|
|
Daveme
|
36 |
14K |
5 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
36
|
14K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q3 Financial Results and Operational Highlights
|
|
Daveme
|
177 |
60K |
10 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
177
|
60K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Class Action
|
|
Daveme
|
218 |
67K |
3 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
218
|
67K
|
3
|
|
ASX - By Stock
|
AGE |
Re:
Ann: App 3Y - Change of Director's Interest Notice
|
|
Daveme
|
8 |
2.8K |
1 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
8
|
2.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
Daveme
|
19 |
6.6K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
19
|
6.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
0 |
24/04/22 |
24/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Daveme
|
1.0K |
326K |
1 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
1.0K
|
326K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
9 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
4 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
6 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
1 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
2 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
1 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
8 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
8
|
|
ASX - By Stock
|
SVL |
Re:
Ann: Increasing Gold and Zinc in Drilling at Bowdens Silver
|
|
Daveme
|
18 |
13K |
3 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
18
|
13K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
Daveme
|
905 |
288K |
6 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
905
|
288K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Daveme
|
1.0K |
326K |
1 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
1.0K
|
326K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Daveme
|
1.0K |
326K |
1 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
1.0K
|
326K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Daveme
|
4.7K |
1.1M |
6 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
1 |
08/01/22 |
08/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
2 |
08/01/22 |
08/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
1 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
2 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Daveme
|
17K |
6.6M |
2 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
Daveme
|
1.5K |
500K |
0 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
1.5K
|
500K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Daveme
|
211 |
72K |
2 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
72K
|
2
|
|
ASX - By Stock
|
THR |
Re:
The forgotten USA Uranium Play
|
|
Daveme
|
167 |
53K |
0 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
167
|
53K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
The great Msb short unwind
|
|
Daveme
|
140 |
38K |
1 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
140
|
38K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Novartis walked due to "sub par data".
|
|
Daveme
|
143 |
41K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
143
|
41K
|
0
|
|
ASX - By Stock
|
THR |
Re:
Ann: Trading Halt
|
|
Daveme
|
17 |
5.7K |
0 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
17
|
5.7K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Greatest Benefit in Diabetics and Ischemics
|
|
Daveme
|
304 |
95K |
1 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
304
|
95K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Greatest Benefit in Diabetics and Ischemics
|
|
Daveme
|
304 |
95K |
2 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
304
|
95K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Daveme
|
10K |
3.0M |
1 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Daveme
|
10K |
3.0M |
8 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Daveme
|
5.2K |
2.5M |
5 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
5.2K
|
2.5M
|
5
|
|